PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.10%
Net income growth above 1.5x MCHP's 1.03%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
5.62%
Some D&A expansion while MCHP is negative at -0.10%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-57.14%
Negative yoy deferred tax while MCHP stands at 141.13%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
199.59%
Well above MCHP's 279.62% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
87.63%
Some inventory rise while MCHP is negative at -162.68%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
272.97%
Growth well above MCHP's 225.97%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-841.00%
Both negative yoy, with MCHP at -71.65%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-43.00%
Negative yoy CFO while MCHP is 24.27%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.77%
CapEx growth well above MCHP's 8.64%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
7.91%
Purchases growth of 7.91% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-27.75%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-129.65%
We reduce yoy invests while MCHP stands at 9.59%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-46.67%
Both yoy lines negative, with MCHP at -90.99%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-0.66%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.